‘Money has spoken’: Why Chinese biotech CEOs tell Fierce they’re unfazed about rising US tensions

You might assume Chinese biotechs are enduring sleepless nights worrying about whether the ramping up of rhetoric in the U.S. is putting their new financial gains in peril. But the companies Fierce spoke to remained unconcerned.